 "Johnson & Johnson")
Johnson & Johnson pause could be lifted soon
US federal health officials are leaning toward lifting their recommended pause on the use of Johnson & Johnson’s coronavirus vaccine after finding only a limited number of additional cases of a rare blood clotting disorder among recipients. Instead, the drug regulator is likely to attach a warning to the vaccine’s label to inform health practitioners — and the public — about the exceedingly uncommon, but dangerous possible side effect. Officials are waiting to act until they hear from a committee of outside experts who advise the CDC The committee is scheduled to meet
